Zusammenfassung

• Anhänge (0 geändert, 0 hinzugefügt, 1 gelöscht)
  • Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf
• Objekte (1 geändert, 0 hinzugefügt, 0 gelöscht)
  • Wikiderm.EntryClass[0]

Details

Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf

Author

...	...	@@ -1,1 +1,0 @@
1		-XWiki.Dermatologie_Kompendium

Größe

...	...	@@ -1,1 +1,0 @@
1		-620.9 KB

Inhalt

Wikiderm.EntryClass[0]

Eintrag

...	...	@@ -65,48 +65,9 @@
65	65	(% class="Feature" %)Bsp:(%%) Mycoplasma pneumoniae, HIV
66	66
67	67	(% class="Eintrag-2" %)
68		-(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) (% class="Abbreviation" %)AGEP(%%)
	68	+(% class="Feature" %)DD:(%%) (% class="Abbreviation" %)AGEP(%%), Dermatitis herpetiformis, eosinophile pustulöse Follikulitis Ofuji, Impetigo contagiosa, Pemphigus foliaceus, Psoriasis pustulosa
69	69
70		-(% class="Ebene-1" %)
71		-(% class="Bullet" %)-(%%) Dermatitis herpetiformis
72		-
73		-(% class="Ebene-1" %)
74		-(% class="Bullet" %)-(%%) eosinophile pustulöse Follikulitis Ofuji
75		-
76		-(% class="Ebene-1" %)
77		-(% class="Bullet" %)-(%%) Impetigo contagiosa
78		-
79		-(% class="Ebene-1" %)
80		-(% class="Bullet" %)-(%%) Pemphigus foliaceus
81		-
82	82	(% class="Eintrag-2" %)
83		-
84		-
85		-(% class="Ebene-1" %)
86		-(% class="Bullet" %)-(%%) Psoriasis pustulosa
87		-
88		-(% class="Ebene-1" %)
89		-(% class="Bullet" %)-(%%) Tinea incognito
90		-
91		-(% class="Ebene-2" %)
92		-(% class="Feature" %)Lit:(%%) [[Kalkan, G., Demirseren, D. D, Güney, C. A, & Aktaş, A. (2020). A case of tinea incognito mimicking subcorneal pustular dermatosis. Dermatology Online Journal, 26(2)>>url:https://escholarship.org/uc/item/46g9x55w]]
93		-
94		-(% class="Eintrag-2" %)
95		-(% class="Feature" %)Lit:(%%) (% class="Bullet" %)-(%%) {{pdfbox Datei="Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf" /}}
96		-
97		-(% class="Ebene-1" %)
98		-(% class="Bullet" %)-(%%) Open Access Maced J Med Sci. 2020 Jun 05; 8(T1):12-15. [[https:~~/~~/doi.org/10.3889/oamjms.2020.4870>>url:https://doi.org/10.3889/oamjms.2020.4870]]
99		-
100		-(% class="Ebene-1" %)
101		-(% class="Bullet" %)-(%%) International Journal of Women's Dermatology, Volume 6, Issue 3, 2020, Pages 131-136, ISSN 2352-6475, [[https:~~/~~/doi.org/10.1016/j.ijwd.2020.02.003>>url:https://doi.org/10.1016/j.ijwd.2020.02.003]]
102		-
103		-(% class="Ebene-1" %)
104		-(% class="Bullet" %)-(%%) SAGE Open Med Case Rep. 2019 Jan 30;7:2050313X19826432. [[http:~~/~~/doi.org/10.1177/2050313X19826432>>url:http://doi.org/10.1177/2050313X19826432]]
105		-
106		-(% class="Ebene-1" %)
107		-(% class="Bullet" %)-(%%) JAAD Case Rep. 2022 Jan 21;21:185-188. [[http:~~/~~/doi.org/10.1016/j.jdcr.2021.04.039>>url:http://doi.org/10.1016/j.jdcr.2021.04.039]]
108		-
109		-(% class="Eintrag-2" %)
110	110	(% class="Feature" %)Th:(%%) (% class="Bullet" %)-(%%) lokal
111	111
112	112	(% class="Ebene-2" %)
...	...	@@ -113,12 +113,6 @@
113	113	(% class="Bullet" %)-(%%) Farbstoffe (**[[Antiseptika]]**)
114	114
115	115	(% class="Ebene-2" %)
116		-(% class="Bullet" %)-(%%) Mometasonfuroat
117		-
118		-(% class="Ebene-3" %)
119		-(% class="Feature" %)Lit:(%%) Dermatol Ther. 2021 Nov 27:e15235. [[http:~~/~~/doi.org/10.1111/dth.15235>>url:http://doi.org/10.1111/dth.15235]]
120		-
121		-(% class="Ebene-2" %)
122	122	(% class="Bullet" %)-(%%) Tacalcitol
123	123
124	124	(% class="Ebene-3" %)
...	...	@@ -136,12 +136,6 @@
136	136	(% class="Ebene-5" %)
137	137	(% class="Feature" %)Lit:(%%) (% class="Abbreviation" %)CR(%%)
138	138
139		-(% class="Ebene-2" %)
140		-(% class="Bullet" %)-(%%) Dapson Gel
141		-
142		-(% class="Ebene-3" %)
143		-(% class="Feature" %)Lit:(%%) J Dermatol. 2019 Jun 24. [[http:~~/~~/doi.org/10.1111/1346-8138.14953>>url:http://doi.org/10.1111/1346-8138.14953]]
144		-
145	145	(% class="Ebene-1" %)
146	146	(% class="Bullet" %)-(%%) systemisch
147	147
...	...	@@ -185,12 +185,6 @@
185	185	(% class="Feature" %)Lit:(%%) Dermatol Ther. 2019 Jan 14:e12818. [[http:~~/~~/doi.org/10.1111/dth.12818>>url:http://doi.org/10.1111/dth.12818]]
186	186
187	187	(% class="Ebene-2" %)
188		-(% class="Bullet" %)-(%%) Apremilast
189		-
190		-(% class="Ebene-3" %)
191		-(% class="Feature" %)Lit:(%%) Australas J Dermatol. 2020 Feb 11. [[http:~~/~~/doi.org/10.1111/ajd.13253>>url:http://doi.org/10.1111/ajd.13253]]
192		-
193		-(% class="Ebene-2" %)
194	194	(% class="Bullet" %)-(%%) Anti-TNF-alpha
195	195
196	196	(% class="Ebene-3" %)
...	...	@@ -197,8 +197,14 @@
197	197	(% class="Feature" %)Stoff:(%%) (% class="Bullet" %)-(%%) **[[Infliximab]]**
198	198
199	199	(% class="Ebene-4" %)
200		-(% class="Feature" %)Lit:(%%) Arch Dermatol 2001; 137: 1571-4, Dermatol Ther. 2022 May 4:e15552. [[http:~~/~~/doi.org/10.1111/dth.15552>>url:http://doi.org/10.1111/dth.15552]]
	143	+(% class="Feature" %)Phar:(%%) Remicade^^®^^
201	201
	145	+(% class="Ebene-4" %)
	146	+(% class="Feature" %)Dos:(%%) 5 mg/kg i.v.
	147	+
	148	+(% class="Ebene-4" %)
	149	+(% class="Feature" %)Lit:(%%) Arch Dermatol 2001; 137: 1571-4
	150	+
202	202	(% class="Ebene-3" %)
203	203	(% class="Bullet" %)-(%%) Adalimumab
204	204
...	...	@@ -206,11 +206,4 @@
206	206	(% class="Feature" %)Lit:(%%) Ann Dermatol Venereol. 2013 Dec;140(12):797-800 (Frankreich)
207	207
208	208	(% class="Ebene-5" %)
209		-(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%)
210		-
211		-(% class="Ebene-2" %)
212		-(% class="Bullet" %)-(%%) Guselkumab
213		-
214		-(% class="Ebene-3" %)
215		-(% class="Feature" %)Lit:(%%) Int J Dermatol. 2021 Apr;60(4):e153-e154. [[http:~~/~~/doi.org/10.1111/ijd.15311>>url:http://doi.org/10.1111/ijd.15311]]
216		-
	158	+(% class="Feature" %)PT:(%%) CR